Guj. Terce Labs.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE499G01013
NSEID:
BSEID: 524314

INR

62.39

2.17 (3.6%)

BSENSE

Apr 11, 12:48 PM

BSE+NSE Vol: 912

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Divi's Lab.

Cipla

Sun Pharma.Inds.

Torrent Pharma

Guj. Terce Labs.

Roopa Industries

Mankind Pharma

Deccan Healthcar

Vista Pharma.

Shelter Pharma

Mono Pharmacare

Why is Gujarat Terce Laboratories Ltd ?

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.08%

Poor long term growth as Net Sales has grown by an annual rate of 6.69% over the last 5 years
Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times

Stock is technically in a Mildly Bearish range

The technical trend has deteriorated from Sideways on 07-Apr-25 and has generated -1.96% returns since then
Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Guj. Terce Labs. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Guj. Terce Labs.

7.7%

0.14

56.77%

SENSEX

0.45%

0.03

14.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

6.69%

EBIT Growth (5y)

26.46%

EBIT to Interest (avg)

-0.35

Debt to EBITDA (avg)

1.09

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

3.76

Tax Ratio

9.51%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

7.64%

ROE (avg)

5.89%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

5.04

EV to EBIT

14.03

EV to EBITDA

12.67

EV to Capital Employed

3.82

EV to Sales

0.97

PEG Ratio

0.03

Dividend Yield

ROCE (Latest)

25.39%

ROE (Latest)

33.30%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company

PAT(9M)

Higher at Rs 2.41 Cr

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...

Here's what is working for Guj. Terce Labs.

Profit After Tax (PAT) - Half Yearly

At Rs 2.49 cr has Grown at 149.00 %

Year on Year (YoY)

MOJO Watch

PAT trend is very positive

PAT (Rs Cr)

Profit After Tax (PAT) - Half Yearly

Higher at Rs 2.49 cr

than preceding 12 month period ended Dec 2024 of Rs 1.46 cr

MOJO Watch

In the half year the company has already crossed PAT of the previous twelve months

PAT (Rs Cr)